NGN Capital Overview

  • Investor Type

  • Venture Capital

  • Status

  • Active

  • Professionals

  • 4

Professionals
  • Investments

  • 57

  • Portfolio

  • 4

  • Exits

  • 30

Exits

NGN Capital General Information

Description

Founded in 2003, NGN Capital is a venture capital firm based in Stamford, Connecticut. The firm prefers to invest in early-stage and later-stage companies operating in healthcare, life sciences, oncology, and TMT sectors based in the United States and Europe.

Contact Information

Website
www.ngncapital.com
Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 60 Long Ridge Road
  • Suite 402
  • Stamford, CT 06902
  • United States
+1 (212) 000-0000

NGN Capital Investments (57)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
OptiScan 20-Mar-2019 Later Stage VC 0000 Monitoring Equipment Bankruptcy: Admin/Reorg 0000000 0000000000
0000000 0000000000 05-Jul-2017 00000 00000 000.00 Biotechnology Generating Revenue 00000 000000 00.0
00000000000 01-Feb-2017 00000 00000 0000 Surgical Devices Generating Revenue
0000000 0000000000 07-Jan-2016 00000 00000 0000 Biotechnology Generating Revenue 00000 000000 00.0
000000 0000000 23-Jul-2014 00000 00000 000.00 Biotechnology Generating Revenue/Not Profitable
0000000 0000000000 12-Mar-2014 00000 00000 000.00 Biotechnology Generating Revenue 00000 000000 00.0
0000 0000000 00000 05-Mar-2014 00000 00000 00.00 Business/Productivity Software Out of Business
000000000 05-Mar-2013 00000 00000 000.00 Surgical Devices Generating Revenue 00000 000000 00.0
Cerapedics 12-Dec-2012 Later Stage VC 0000 Biotechnology Generating Revenue 0000000 0000000000
PIN Pharma 01-Jan-2012 Early Stage VC 00.000 Biotechnology Generating Revenue 0000 0000000
You’re viewing 10 of 57 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NGN Capital Exits (30)

Company Name Exit Date Exit Type Exit Size
Cardiovalve 25-Jan-2022 Merger/Acquisition 00000
0000 0000000 00000 17-Dec-2021 000 00 00000000
000 000000 01-Apr-2021 000000000 00000000
00000000 02-Jun-2020 0000000000: 000000
000000 0000000 06-Mar-2020 000 00000
0000000 0000000000 01-Aug-2018 000000000000000000 00000
0000000 000000 23-Jan-2017 000000000000000000 00000
000000000 01-Oct-2016 000000000000000000 00.000
SpineView 01-Oct-2016 Out of Business
TME Pharma 30-Sep-2016 IPO
You’re viewing 10 of 30 exits. Get the full list »

NGN Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore NGN Capital‘s full profile, request access.

Request a free trial

NGN Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NGN Capital Team (20)

Name Title Deals Funds Boards Office
Alexander Cuomo Chief Financial Officer Stamford, CT
Kenneth Abramowitz Co-Founder & Managing General Partner 00 0 0 Stamford, CT
Peter Johann Ph.D Managing General Partner 0 0 0 Heidelberg, Germany
Kenneth Gorelick MD Venture Partner Stamford, CT
William Gedale JD Senior Advisor & Co-Founder 0 Stamford, CT
You’re viewing 5 of 20 team members. Get the full list »

NGN Capital Co-Investors (6)

Name With Exits Lead Partner Series Industry
Biobrit 1 0 0 Series chart Industry bar
Crown Venture Fund 0 0 0 Series chart Industry bar
Revelation Partners 0 0 0 Series chart Industry bar
Wexford Capital 0 0 0 Series chart Industry bar
Xeraya Capital 0 0 0 Series chart Industry bar
You’re viewing 5 of 6 co-investors. Get the full list »